Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.12B |
| Enterprise Value | 3.42B |
| P/E Ratio | -7.6 |
| PEG Ratio | 0.19 |
| Price/Sales Ratio | 1.57 |
| Price/Book Ratio | 1.24 |
| Enterprise/Revenue | 1.7 |
| Enterprise/EBITDA | -17.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.2 |
| Operating Margin | -0.1 |
AD
Management Effectiveness
| Return On Assets | -0.1 |
| Return On Equity | -0.15 |
Income Statement
| Revenue | 1.85B |
| Revenue/Share | 2.19 |
| Gross Profit | 1.04B |
| EBITDA | -94.07M |
| Net Income | -329.56M |
| Diluted EPS | -0.42 |
Balance Sheet
| Total Cash | 489.9M |
| Total Cash/Share | 0.62 |
| Total Debt | 715.15M |
| Total Debt/Equity | 0.33 |
| Current Ratio | 1.7 |
| Book Value Per Share | 2.86 |
Price History
| 52-Week Change | -18.07 |
| 52-Week High | 5.27 |
| 52-Week Low | 2.85 |
| Moving Average 50 Days | 3.52 |
| Moving Average 200 Days | 4.01 |
Statistics
| Average Volume | 40.65M |
| Shares Outstanding | 791.93M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.05 |
| Last Split Factor | 2:1 |
| Last Split Date | July 16, 2015 |
AD
